Principal Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $155M | Sell |
|
|||||
|
2025
Q1 | $162M | Sell |
|
|||||
|
2024
Q4 | $134M | Buy |
|
|||||
|
2024
Q3 | $122M | Buy |
|
|||||
|
2024
Q2 | $95.5M | Sell |
|
|||||
|
2024
Q1 | $106M | Sell |
|
|||||
|
2023
Q4 | $118M | Sell |
|
|||||
|
2023
Q3 | $126M | Buy |
|
|||||
|
2023
Q2 | $121M | Buy |
|
|||||
|
2023
Q1 | $127M | Buy |
|
|||||
|
2022
Q4 | $130M | Sell |
|
|||||
|
2022
Q3 | $95.7M | Buy |
|
|||||
|
2022
Q2 | $92.2M | Sell |
|
|||||
|
2022
Q1 | $90.1M | Buy |
|
|||||
|
2021
Q4 | $107M | Sell |
|
|||||
|
2021
Q3 | $105M | Sell |
|
|||||
|
2021
Q2 | $104M | Buy |
|
|||||
|
2021
Q1 | $96.5M | Sell |
|
|||||
|
2020
Q4 | $94.1M | Sell |
|
|||||
|
2020
Q3 | $108M | Sell |
|
|||||
|
2020
Q2 | $139M | Buy |
|
|||||
|
2020
Q1 | $132M | Buy |
|
|||||
|
2019
Q4 | $114M | Sell |
|
|||||
|
2019
Q3 | $115M | Sell |
|
|||||
|
2019
Q2 | $123M | Sell |
|
|||||
|
2019
Q1 | $121M | Sell |
|
|||||
|
2018
Q4 | $127M | Sell |
|
|||||
|
2018
Q3 | $167M | Buy |
|
|||||
|
2018
Q2 | $152M | Sell |
|
|||||
|
2018
Q1 | $222M | Buy |
|
|||||
|
2017
Q4 | $200M | Sell |
|
|||||
|
2017
Q3 | $263M | Sell |
|
|||||
|
2017
Q2 | $277M | Buy |
|
|||||
|
2017
Q1 | $188M | Sell |
|
|||||
|
2016
Q4 | $243M | Buy |
|
|||||
|
2016
Q3 | $261M | Buy |
|
|||||
|
2016
Q2 | $263M | Sell |
|
|||||
|
2016
Q1 | $324M | Buy |
|
|||||
|
2015
Q4 | $304M | Sell |
|
|||||
|
2015
Q3 | $317M | Buy |
|
|||||
|
2015
Q2 | $348M | Buy |
|
|||||
|
2015
Q1 | $256M | Sell |
|
|||||
|
2014
Q4 | $285M | Buy |
|
|||||
|
2014
Q3 | $301M | Buy |
|
|||||
|
2014
Q2 | $222M | Sell |
|
|||||
|
2014
Q1 | $237M | Buy |
|
|||||
|
2013
Q4 | $251M | Buy |
|
|||||
|
2013
Q3 | $208M | Buy |
|
|||||
|
2013
Q2 | $131M | Buy |
|